Xtant Medical Holdings XTNT
NYSE XTNT
$0.33 +0.00 (+1.48%)
At close: Aug 20, 2026 · 11:05 AM UTC

Xtant Medical Holdings (XTNT) Interest & Investment Income (2023)

Xtant Medical Holdings (XTNT) posted quarterly Interest & Investment Income of $16000.0 for Q4 2023, down 66.67% quarter-over-quarter from $48000.0 in Q3 2023.

Xtant Medical Holdings (XTNT) Interest & Investment Income (2023) Analysis & Trends

Xtant Medical Holdings (XTNT) has reported Interest & Investment Income for 1 consecutive years, with $16000.0 the latest figure, recorded in Q4 2023.

  • In Q4 2023, Interest & Investment Income changed N/A year-over-year to $16000.0; the TTM figure through Dec 2023 stood at $149000.0 (changed N/A YoY), while the FY2023 annual figure was $149000.0, up 380.65% from the prior year.
  • Interest & Investment Income retreated to $16000.0 in Q4 2023 per XTNT's latest filing, from $48000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $86000.0 in Q1 2023 and bottomed at -$1000.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Abbott Laboratories 200.20 Bn 194.60 Bn 7.27 Bn 52.00 Mn
2 Stryker 129.69 Bn 126.21 Bn 4.50 Bn -
3 Medtronic 120.14 Bn 110.92 Bn 6.41 Bn -
4 Boston Scientific 74.16 Bn 73.62 Bn 3.85 Bn -
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn 30.00 Mn
6 Dexcom 34.57 Bn 32.62 Bn 830.00 Mn -
7 GE HealthCare Technologies 34.09 Bn 31.98 Bn 2.18 Bn -
8 Koninklijke Philips 26.49 Bn 23.17 Bn 4.55 Bn 73.23 Mn
9 Steris 23.19 Bn 22.70 Bn 684.20 Mn -
10 Xtant Medical Holdings 46.73 Mn 29.13 Mn 17.75 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 16,000.00
Sep 30, 2023 48,000.00
Jun 30, 2023 -1,000.00
Mar 31, 2023 86,000.00